The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of obesity on response in 751 myeloma patients receiving lenalidomide, bortezomib, and dexamethasone (RVd) induction.
 
R Donald Harvey
Consulting or Advisory Role - Genentech; HERON; Spectrum Pharmaceuticals
Speakers' Bureau - Genentech
Research Funding - Agensys (Inst); Amgen (Inst); ArQule (Inst); AstraZeneca (Inst); AVEO (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Celgene (Inst); Cleave Biosciences (Inst); Eisai (Inst); Merck (Inst); Millennium (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst); Takeda (Inst)
 
Jonathan L. Kaufman
Honoraria - Janssen
Consulting or Advisory Role - Abbvie; Janssen; Pharmacyclics; Roche; Takeda
Research Funding - Celgene (Inst); Merck (Inst); Novartis (Inst)
 
Leonard T. Heffner
No Relationships to Disclose
 
Craig C. Hofmeister
Consulting or Advisory Role - Celgene; Thrasos Therapeutics
Research Funding - Arno Therapeutics; Bristol-Myers Squibb; Celgene; Janssen Oncology; Karyopharm Therapeutics; Takeda
Travel, Accommodations, Expenses - Amgen
 
Mahdav V. Dhodapkar
No Relationships to Disclose
 
Sagar Lonial
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen Oncology; Millennium; Novartis; Onyx
 
Ajay K. Nooka
Consulting or Advisory Role - Novartis; Onyx